1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (1812)
  2. Meeting Abstract (932)
  3. Book Section (169)
  4. Review (156)
  5. Editorial (44)
  6. Conference Paper (40)
  7. Guidelines (31)
  8. Miscellaneous (18)
  9. Correspondence (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Molecular Imaging and Therapy Service (3230)
  2. Radiology, Department of (3052)
  3. GSK Faculty (1475)
  4. Sloan Kettering Institute Faculty (1241)
  5. Molecular Pharmacology and Chemistry Program Faculty (1226)
  6. Department of Medicine (983)

More Groups

People
  1. Steven Larson (957)
  2. Heiko Schoder (543)
  3. Neeta Pandit-Taskar (342)
  4. John Humm (281)
  5. Hebert Vargas Alvarez (267)
  6. Lisa Bodei (205)

More People

Years
  1. 2025 (40)
  2. 2024 (129)
  3. 2023 (176)
  4. 2022 (175)
  5. 2021 (197)
  6. 2020 (195)

More Years

Publications
  1. Journal of Nuclear Medicine (569)
  2. Journal of Clinical Oncology (248)
  3. European Journal of Nuclear Medicine and Molecular Imaging (130)
  4. Blood (97)
  5. International Journal of Radiation Oncology, Biology, Physics (73)
  6. Clinical Nuclear Medicine (72)

More Publications

Publishers
  1. Society of Nuclear Medicine (569)
  2. Springer (430)
  3. Elsevier Inc. (303)
  4. American Society of Clinical Oncology (259)
  5. Lippincott Williams & Wilkins (154)
  6. American Association for Cancer Research (150)

More Publishers

Results (3230)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Machine learning-enhanced patient-specific dosimetry: Automatic segmentation voxel dosimetry in open source TriDFusion (3DF) software
    Meeting Abstract

    Lafontaine, D.; Marquis, H.; Kesner, A.; Kirov, A.; Talarico, O.; Krebs, S.; Sofocleous, C.; Schoder, H.; Humm, J.; Carter, L.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Standardized reporting of oncologic functional response: Oncologic response lexicon for PET/CT
    Meeting Abstract

    Wray, R.; Do, R.; Schoder, H.; Yeh, R.; Mayerhoefer, M.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Dose escalation and curative therapy of colorectal cancer with anti-GPA33 self-assembling and disassembling (SADA) actinium-225 alpha pretargeted radioimmunotherapy
    Meeting Abstract

    Aguirre, N.; Veach, D.; Guo, H. F.; Espinosa-Cotton, M.; Fung, E.; Xu, H.; Feng, Y.; Leung, K.; Cheung, I.; Carrasco, S.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Anti-GPA33 pretargeted radioimmunotherapy (PRIT) of colorectal cancer (CRC) using a self-assembling and dis-assembling (SADA) bispecific antibody to deliver 177Lu-bivalent benzyl-DOTA
    Meeting Abstract

    Le Roux, A.; Fung, E.; Xu, H.; Vargas, D. B.; Rinne, S. S.; Guo, H. F.; Leung, K.; Feng, Y.; Cheung, I.; Ouerfelli, O.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Bone marrow dosimetry exploratory analysis from the phase 3 SIERRA trial of (131)I-apamistamab prior to HCT in relapsed/refractory acute myeloid leukemia
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M.; Leung, E.; Spross, J.; Li, K.; Desai, A.; Brodin, P.; Wahl, R.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Development of PET response criteria in neuroendocrine tumors (PERCIN)
    Meeting Abstract

    Chaban, A.; Dinkel, V.; Eiber, M.; Song, Y.; Brosch-Lenz, J.; Krebs, S.; Bodei, L.; Weber, W.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Modeling-based assessment of exposure measurements after high-dose targeted (131)I-apamistamab: Results and analyses from the phase III SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Chen, L.; Serencsits, B.; Prasad, K.; Senglaub, T.; Zgaljardic, M.; Spross, J.; Desai, A.; Brodin, P.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Primary results of NRG-RTOG1106/ECOG-ACRIN 6697: A randomized phase II trial of individualized adaptive (chemo)radiotherapy using midtreatment (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in stage III non–small cell lung cancer
    Journal Article

    Kong, F. M.; Hu, C.; Pryma, D. A.; Duan, F.; Matuszak, M.; Xiao, Y.; Ten Haken, R.; Siegel, M. J.; Hanna, L.; Curran, W. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • The radiolabeling of [(161)Tb]Tb-PSMA-617 by a novel radiolabeling method and preclinical evaluation by in vitro/in vivo methods
    Journal Article

    Uygur, E.; Sezgin, C.; Parlak, Y.; Karatay, K. B.; Arıkbaşı, B.; Avcıbaşı, U.; Toklu, T.; Barutça, S.; Harmanşah, C.; Sözen, T. S.; more...
    Journal of Radioanalytical and Nuclear Chemistry (2024)

    Fulltext@MSK | Save